Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Orchard Therapeutics, now part of Kyowa Kirin, has achieved a significant breakthrough with the approval of Lenmeldy™ by the U.S. Food and Drug Administration. Lenmeldy, previously...
A group of researchers at Brown University has devised an innovative approach to swiftly predict diverse protein configurations using machine learning. Their method aims...
The recent approval by the Food and Drug Administration of a novel cellular immunotherapy at Moffitt Cancer Center marks a pivotal moment for patients battling advanced melanoma. This groundbreaking therapy...
Otsuka Pharmaceutical Development & Commercialization, Inc, in collaboration with Otsuka Pharmaceutical Co., Ltd, and Visterra, Inc., an Otsuka group company, jointly announce a significant development: the U.S. Food and Drug Administration...
Nuvalent, a biopharmaceutical company in the clinical stage, has declared that the U.S. Food and Drug Administration has accorded breakthrough therapy designation to NVL-520 for treating individuals...
Iovance Biotherapeutics, a leading biotechnology company committed to pioneering, developing, and delivering innovative polyclonal tumor infiltrating lymphocyte cell therapies for cancer patients...
Alector recently announced a significant milestone in the potential treatment of Frontotemporal Dementia with a progranulin gene mutation. The U.S. Food and Drug Administration...
Ensysce Biosciences, a clinical-stage company dedicated to enhancing prescription drug safety through innovative chemistry, has received notification from the U.S. Food and Drug Administration...
Santhera Pharmaceuticals has recently announced the approval of AGAMREE® in the United Kingdom for the treatment of Duchenne muscular dystrophy in patients aged 4 and above, irrespective of their underlying mutation...
Coherus BioSciences, a biopharmaceutical company in the commercial stage, has received approval from the U.S. Food and Drug Administration for its UDENYCA ONBODY. This is an on-body injector presentation of UDENYCA...
